ABSTRACT Low-energy conformations of methionineenkephalin were generated by means of an empirical method of computation. Many compact conformations, including those containing various standard bends, were of comparable energy. However, one conformation was found to have a potential energy about 5 kcal/mol (21 X 103 J/mol) below that of the large group of compact conformations. In this conformation, the 3-glycyl and en lalanyl residues form a bend of type II'. The conformation is stabilized by a hydrogen bond between the OH group of the 1-tyrosine side chain and the C='O group of 3-glycine or 4-phenylalanine. Thie phenylalanine and methionine side chains are relatively unrestricted. The conformation is consistent with published nuclear magnetic resonance parameters coupling constants, temperature dependence of the chemical shift, and spin-lattice reLaxation times. It is likely that the molecule undergoes a conformational change when it is bound to the receptor. Leucineenkephalin appears to have the same conformation as its methionine homolog. Enkephalin is an endogenous peptide from mammalian brain with morphine-like activity (1-4). Porcine enkephalin is composed of two pentapeptides (5). The amino acid sequence of the major component, Met-enkephalin, is Tyr-Gly-Gly-Phe-Met. The minor component, Leu-enkephalin, has leucine in place of methionine. In enkephalin extracted from bovine brain, the peptide containing leucine is the major component (4). Enkephalin exhibits an analgesic effect that is similar to that of morphine and its analogs, it competes with them in binding, and it is inhibited by morphine antagonists such as naloxone (1, 4) . Thus, it is likely that enkephalin binds to the same stereospecific receptor site as does morphine and the other opiates. In order to clarify the mechanism of action at the opiate receptor site, comparisons between the three-dimensional structure of opiates and of enkephalin are of interest.
Conformational models of Met-enkephalin have been proposed from the results of nuclear magnetic resonance measurements (6) (7) (8) (9) and on the basis of presumed structural similarities with morphine and related analgesics (10 that helped in selecting starting conformations likely to give low-energy structures after minimization. The strategies, to be described in Methods, can be summarized as follows. The starting conformations included several regular repeating conformations of the pentapeptide, various forms of chain reversals (bends), combinations of conformations that are of low energy for single amino acid residues or dipeptides, and compact conformations obtained by model building. Energy minimizations were then carried out for these structures. Side-chain orientations were varied systematically to test the effect of possible side chain-backbone interactions.
METHODS The nomenclature and conventions adopted by an IUPAC-IUB Commission were used (12) . The conformational energy calculations were carried out with ECEPP (Empirical Conformational Energy Program for Peptides). t The empirical potential energy functions and energy parameters used are those described by Momany et al. (13) . Standard residue geometries were used, as supplied in ECEPP. Uncharged NH2 and COOH groups were used as end groups. Solvent effects were not included. Energy minimization was carried out by using the algorithm of Powell (14) with a convergence criterion of 0.01 kcal/mol (41.8 J/mol). Termination also occurred when each of the variable dihedral angles changed by less than 0.050 between any two iterations. All dihedral angles, including those around peptide bonds (co), were treated as variables of minimization except the one around the bond between C' and the OH group of the COOH-terminal residue. This dihedral angle was fixed at 1800.
Selection of Starting Conformations. The selection of starting conformations is explained in strategies a to C. Except when noted otherwise, the starting dihedral angles for side chains were taken to be those that occur in the lowest energy conformations for any given choice of qs and 41 in blocked single residues (15) Strategy e. Four starting conformations were generated from low-energy dipeptides. Two successive residues along the sequence were placed in the lowest energy conformation for the corresponding dipeptide, § and the other three residues were placed in compatible low-energy dipeptide conformations. For example, Gly3-Phe4 was assigned the lowest energy Gly-Phe conformation, § and Gly2 and Met5 were placed in that lowest Gly-Gly and Phe-Met conformation, respectively, which contains the previously assigned conformation of Gly3 or Phe4; a similar procedure was used for Tyr'.
Strategy f. Published structural models were also used as a basis to select starting conformations. The structures proposed in nuclear.magnetic resonance studies (6) (7) (8) minimizations. In addition, many more conformations were tested and eliminated in various steps of the strategies.
RESULTS
Computations on Met-enkephalin The results of the calculations are summarized in Fig. 1 , which shows all computed conformations with energy less than 11 kcal/mol above the minimum found in this study. The conformations are classified into six groups, according to the starting conformations from which they were obtained (see legend to Fig. 1 ). The dihedral angles of several low-energy conformations are listed in Table 1 .
Reference Conformations (group A of Fig. 1 ). Three regular (repeating) conformations were selected as reference states. The a-helix (conformation 1 in Fig. 1 ) is known to be of low energy for oligopeptides. The extended structure (conformation 2) is of low energy for many amino acids (15) and it has the least amount of interaction between the side chains in enkephalin. The C7eq conformation (conformation 3) is also of low energy for many amino acids (15) . The energy of all three conformations is rather high in comparison with that of many compact conformations (AE 2 9 kcal/mol). This suggests that interactions in the latter play a significant stabilizing role-and that the selection strategies used in this study were efficient in generating low-energy conformations.
Bend Conformations (groups B and D). The energy of all bend conformations falls into a densely populated band at AE > 6.0 kcal/mol, with the exception of variants of the type II' G-P bend (conformations 4, 56 and group C). These low-energy conformations, to be discussed below in detail, are stabilized by a hydrogen bond between the tyrosyl OH and a backbone oxygen. Such a hydrogen bond is not sterically possible in any of the G-G bends, so that no low-energy conformation occurs in group D.
Other Compact Conformations (groups E and F Chemistry: Isogai et al. (15) . This movement of the side chains does not affect the backbone conformation significantly. The starting structure leading to conformation 11 was obtained from a molecular model of conformation 7, in which all dihedral angles of Phe4 and Met5 were adjusted visually so as to make good side chain-side chain and side chain-backbone contacts. In spite of these contacts, the minimized energy in- (6, 7) and of Gibbons (8) . The reported data agree closely. The models proposed by the two groups are similar. Both groups concluded that the molecule has a well-defined conformation.
On the basis of JNH-CaH values, both proposed a type I bend with Gly3 and Phe4 in the central portion (G-P bend) . A G-G bend would not fit the nuclear magnetic resonance data. No stacking of the aromatic side chains was apparent (6) , and the spectra in aqueous solution were stated to be similar to those in dimethyl sulfoxide (6, 8) . It should be noted that the reported coupling constants are just as consistent with the dihedral angles of a G-P type II' bend as with those of a type I bend (16) . Thus, the experimental data are in complete agreement with the coupling constants computed (18, 19) for the preferred conformation that we propose (Table 2) . Agreement is poor only for the JCaH-COH2 of tyrosine, for which more rotational freedom has been suggested (8) than is found in our model. Both groups (6, 8) reported a small temperature coefficient for the chemical shift of the methionyl N-H. This, too, agrees with our model in which accessibility of the NH group of methionine is low (Fig. 2) .
Bleich et al. (9) measured the 1H and 13C relaxation behavior of Met-enkephalin both in (C2H3)2SO and in a 4:1 H20/2H20 mixture. They concluded that the reorientation of the main peptide chain occurs by means of overall molecular tumbling in both solvents, suggesting a well-defined conformation in Fig. 1). both. The phenylalanyl and methionyl side chains have considerable rotational freedom, but tyrosine is found to be much more restricted in its reorientational motion. These observations, too, are fully consistent with the predictions of our model. However, Bleich et al. (9) suggested tentatively that the conformation of tyrosine might be different in the two solvents, although it is motionally restricted in both. Such an observation -would be harder to reconcile with our model in which there is a preferred conformation for only one orientation of the tyrosyl side chain.
The model proposed by Bradbury et al. (10) does not agree with the nuclear magnetic resonance data (6, 7) . It was shown in this study to have a rather high energy.
Computations on Leu-enkephalin
The methionyl side chain in Met-enkephalin interacts very little with the rest of the molecule in most of the low-energy conformations shown in Fig. 1 . Therefore, one would expect that substitution of leucine for methionine would change the conformation very little. This hypothesis was confirmed by nine energy minimizations on Leu-enkephalin, with starting conformations selected from various conformational groupings in Fig. 1, including 1, 4 , 5, 6, 7, 9, 10, 11, and 14. The relative spacings of the energy minima obtained for Leu-enkephalin were similar to the corresponding ones for Met-enkephalin. The G-P type II' conformations remained much lower in energy than the others. It seems reasonable to say that the conformational preferences are similar in the two enkephalins and that additional computations on Leu-enkephalin would not yield more information.
CONCLUSIONS
Our computations, in essential agreement with presently available nuclear magnetic resonance data, strongly suggest that, when free in solution, enkephalin exists in a preferred conformation (Fig. 2) . This conformation, in the form of a type II' j-bend centered on Gly3-Phe4, is stabilized by noncovalent backbone-backbone interactions and by a hydrogen bond between the OH group of the tyrosyl side chain and the backbone O-C group of either 3-glycine or 4-phenylalanine. The phenylalanyl and methionyl side chains extend away from the backbone and are relatively mobile. In the absence of the hydrogen bond, a large number of conformations can occur, all within a few kcal/mol of each other and none strongly preferred over the others (all conformations in Fig. 2 with AE > 5 kcal/mol). Thus, we predict that, in the absence of this hydrogen bond, the molecule would be very flexible.
Solvent effects were not included explicitly in-our compuChemistry: hogai et al.
tations. It might be argued that the presence of solvent could alter the conformational stabilities. In particular, a polar solvent might destabilize the intramolecular hydrogen bond. We consider it unlikely that the main conclusions would change significently if solvent were considered, because of the following arguments. The lack of flexibility and the general similarity of the structures, observed by nuclear magnetic resonance methods in two solvents, one of them containing water (6-9), coupled with our conclusion about high flexibility in the absence of hydrogen bonding, make it likely that the hydrogen bond persists in polar solvents. Modification of the strength of nonbonded interactions by the solvent-for example, stabilization of hydrophobic interactions between the side chains-can be expected to change free energies by not more than about 2 kcal/mol (20) . Changes of this magnitude are not sufficient to bridge the energy gap between conformations of group C and the others (Fig. 2 ). Both this theoretical study and the nuclear magnetic resonance measurements refer to the free molecule in solution. No definitive conclusions can be drawn from either study concerning the conformation of the molecule bound to the receptor site, since conformational changes can occur upon binding (cf. refs. 8 and 9). Such a conformational change very likely occurs if our proposed model is correct for the free molecule. It has been proposed, on the basis of structural analogies between morphine and various opiates, that the presence of an aromatic OH group and of an ionizable amino group separated by two carbon atoms from the aromatic ring is essential for activity (10, 21, 22) . The NH2-terminal tyrosine of enkephalin fits this requirement, but only if the side chain points away from the molecule. A rotation of tyrosine could take place upon binding to the receptor. In this case, the unique stabilization of the solution conformation (Fig. 2) would be lost, but several medium-energy conformations would be available to the molecule (Fig. 1) . One of these could be the preferred form upon binding.
Our computations offer no clue to aid the characterization of such a preferred conformation.
The receptor affinity or the biological activity of several analogs of enkephalin has been studied (23) (24) (25) . It is tempting to try to correlate the effect of amino acid substitutions with conformational stability. However, substitution may alter affinity or activity because they modify functional groups that are essential either to binding or to action, besides causing changes in conformational preferences. Correlations with the solution conformations are even less feasible, because of the possibility of conformational change upon binding. Such a conformational change is rendered plausible by the observation of the essential retention of activity when Gly2 is replaced by D-Ala (25) but a large decrease of receptor affinity upon replacement with L-Ala (24). The latter substitution is possible in the conformation of Fig. 2 , but the substitution of D-Ala is not because (02, A2) = (-1590, 1000) in Fig. 2 . This conformation is of low energy for L-Ala but of high energy for D-Ala (16) . On the other hand, several medium-energy conformations in Fig. 1 (namely", those with 02 > 0) permit substitution, without conformational changes, more ealy by D-Ala than by L-Ala, so that one of them might be the bound conformation.
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